¿ Hacia una inmunidad sobrehumana contra el SARS-CoV-2? DR Burton, EJ Topol | | |
· P-18 Need an endpoint for a clinical trial? Just ask L Harrelson-Woodlief, S Karnash, H Cohen, K Lee, E Topol, R Califf Controlled Clinical Trials 11 (4), 284, 1990 | 1 | 1990 |
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial SG Ellis, M Tendera, MA de Belder, AJ van Boven, P Widimsky, ... JACC: Cardiovascular Interventions 2 (10), 909-916, 2009 | 76 | 2009 |
1017-68 Influence of Platelet GP IIb/IIIa Receptor Inhibition with c7E3 on the Sequelae of Dissection During Percutaneous Coronary Revascularization AM Lincoff, EJ Topol, RM Califf, HF Weisman, NM Wildermann, SG Ellis Journal of the American College of Cardiology 25 (2), 390A-391A, 1995 | 4 | 1995 |
1018-46 Influence of Randomized Trials on Clinical Practice: A Comparison of Directional Atherectomy and New Device Use Before and After the CAVEAT Trial at CAVEAT Sites N Omoigui, MJ Silver, L Rybicki, M Rosenthal, M Califf, EJ Topol, ... Journal of the American College of Cardiology 25 (2), 393A, 1995 | 2 | 1995 |
1032-116 High Marginal Costs Associated with Routine Placement of Coronary Stents MJ Eisenberg, EJ Topol Journal of the American College of Cardiology 25 (2), 418A, 1995 | | 1995 |
1043-66 Procedural predictors of creatine kinase-MB elevations in the REPLACE-2 study K Gavlick, JC Blankenship, NS Kleiman, JA Bittl, F Feit, EJ Topol, ... Journal of the American College of Cardiology 43 (5S1), A44-A44, 2004 | 1 | 2004 |
1060-80 Female sex: A more important prognostic marker than treatment assignment or comorbid conditions among patients with acute myocardial infarction in the GUSTO V trial HR Reynolds, ME Farkouh, E Swahn, JA White, ZP Sadowski, AM Lincoff, ... Journal of the American College of Cardiology 43 (5S1), A261-A261, 2004 | 1 | 2004 |
1063-54 Long-term clopidogrel therapy is particularly beneficial for patients requiring repeat revascularization after an initial percutaneous coronary intervention J Saw, EJ Topol, SR Steinhubl, D Brennan, PB Berger, DJ Moliterno Journal of the American College of Cardiology 43 (5S1), A50-A50, 2004 | | 2004 |
1100-59 High-dose clopidogrel loading rapidly reduces both platelet inflammatory marker expression and aggregation FJ Zidar, DJ Moliterno, DL Bhatt, K Kottke-Marchant, M Goormastic, ... Journal of the American College of Cardiology 43 (5S1), A64-A64, 2004 | 15 | 2004 |
1116-6 Long-term clopidogrel therapy following percutaneous coronary intervention improves clinical outcome but is not associated with increased bleeding: New insights from the … HD Aronow, SR Steinhubl, DM Brennan, EJ Topol Journal of the American College of Cardiology 43 (5S1), A21-A21, 2004 | 2 | 2004 |
1120-65 Emboli protection improves thrombolysis in myocardial infarction perfusion score in saphenous vein graft intervention JE Exaire, C Haery, DL Bhatt, SJ Brener, SG Ellis, JS Yadar, EJ Topol Journal of the American College of Cardiology 43 (5S1), A76-A76, 2004 | | 2004 |
17: Catheter-based interventions for treatment of acute coronary syndromes PL L'Allier, SG Ellis, EJ Topol Challenges in Acute Coronary Syndromes, 269, 2001 | | 2001 |
23andMe CEO on Her Mission to Shake Up Preventive Care EJ Topol, AE Wojcicki | | 2014 |
28th Bethesda Conference. Task Force 5: Assessment, approval, and regulation of new technology. JS Forrester, EJ Topol, JE Abele, DR Holmes Jr, DJ Skorton Journal of the American College of Cardiology 29 (6), 1171-1179, 1997 | 8 | 1997 |
2nd SYMPHONY investigators. Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes DK McGuire, LK Newby, MV Bhapkar, DJ Moliterno, JS Hochman, ... Am Heart J 147, 246-52, 2004 | 5 | 2004 |
3-year clinical outcomes in a nationwide pragmatic clinical trial of atrial fibrillation screening: mHealth screening to prevent strokes (mSToPS) SR Steinhubl, J Waalen, A Sanyal, AM Edwards, LM Ariniello, GS Ebner, ... As Presented at 2020 AHA Annual Meeting, Scientific Session. American Heart …, 2020 | 3 | 2020 |
3-year Clinical Outcomes in a Nationwide, Randomized, Pragmatic Clinical Trial of Atrial Fibrillation Screening-Mhealth Screening to Prevent Strokes (mstops) SR Steinhubl, J Waalen, A Sanyal, AM Edwards, LM Ariniello, GS Ebner, ... CIRCULATION 142 (24), E491-E491, 2020 | | 2020 |
4. NHS E Topol | | |
500 this week at nejm. org CS Bloss, NJ Schork, EJ Topol, DS Ross, CA Lemos-Júnior, A Camargo, ... | | 2011 |